claim
Senomorphic agents that target matrix metalloproteinases (MMPs) reduce osteoarthritis (OA) symptoms, increase type II collagen, and inhibit chondrocyte degeneration in wild-type (WT) mice.

Authors

Sources

Referenced by nodes (2)